Pharmacological landscape of FDA-approved anticancer drugs reveals sensitivities to ixabepilone, romidepsin, omacetaxine, and carfilzomib in aggressive meningiomas - Jungwirth, Gerhard; Yu, Tao; Liu, Fang; Cao, Junguo; Alaa Eddine, Montadar; Moustafa, Mahmoud; Abdollahi, Amir; Warta, Rolf; Unterberg, Andreas; Herold-Mende, Christel (Clinical cancer research, 2023)
Gesehen am 16.10.2023